Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 11/20 | 0.33 |
| ▸ | CES1 | P23141 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.31 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15739370 | 0.88 | CDC25A (0.34) | CDC25ACES1MGLLALDH1A1ALDH2 | |
| SCHEMBL17014622 | 0.82 | FAAH (0.33) | CDC25ACES1ALOX15MGLLALDH1A1 | |
| SCHEMBL17148357 | 0.81 | CDC25A (0.38) | CDC25ACES1MGLLALDH1A1ALDH2 | |
| SCHEMBL13858494 | 0.80 | MAPK1 (0.38) | CDC25ACES1ALDH1A1ALDH2ALDH3A1 | |
| SCHEMBL15739853 | 0.80 | CDC25A (0.39) | CDC25ACES1MGLLALDH1A1ALDH2 | |
| SCHEMBL17014621 | 0.80 | CDC25A (0.39) | CDC25ACES1MGLLALDH1A1ALDH2 | |
| SCHEMBL15739410 | 0.79 | CDC25A (0.38) | CDC25ACES1MGLLALDH1A1ALDH2 | |
| SCHEMBL15720775 | 0.77 | CDC25A (0.39) | CDC25ACES1MGLLALDH1A1ALDH2 | |
| SCHEMBL15739466 | 0.77 | MAPK1 (0.33) | ALDH1A1 | |
| SCHEMBL17148358 | 0.76 | CDC25A (0.38) | CDC25ACES1MGLLALDH1A1ALDH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9502665-B2 | Organic semiconductor material | E.T.C. S.R.L. (IT) | 2016-11-22 | — | — | US | disclosed |
| US-9502665-B2 | Organic semiconductor material | E.T.C. S.R.L. (IT) | 2016-11-22 | — | — | US | disclosed |
| EP-2920184-B1 | ORGANIC SEMICONDUCTOR MATERIAL | E T C SRL (IT) | 2016-09-14 | — | — | EP | disclosed |
| US-20150236270-A1 | ORGANIC SEMICONDUCTOR MATERIAL | USINVEST LLC | 2015-08-20 | — | — | US | disclosed |
| US-20150236270-A1 | ORGANIC SEMICONDUCTOR MATERIAL | USINVEST LLC | 2015-08-20 | — | — | US | disclosed |
| WO-2014076650-A1 | ORGANIC SEMICONDUCTOR MATERIAL | E.T.C. S.R.L. (IT) | 2014-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150236270-A1 | ORGANIC SEMICONDUCTOR MATERIAL | OR10J3, TST, AS3MT | CDC25A 1100/4885CES1 4514/4885ALOX15 4089/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.